AVITA Medical Inc
NASDAQ:RCEL

Watchlist Manager
AVITA Medical Inc Logo
AVITA Medical Inc
NASDAQ:RCEL
Watchlist
Price: 5.62 USD -2.6% Market Closed
Market Cap: 148.5m USD

Intrinsic Value

The intrinsic value of one RCEL stock under the Base Case scenario is 32.05 USD. Compared to the current market price of 5.62 USD, AVITA Medical Inc is Undervalued by 82%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

RCEL Intrinsic Value
32.05 USD
Undervaluation 82%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
AVITA Medical Inc

Valuation History Unavailable

Historical valuation for RCEL cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about AVITA Medical Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
AVITA Medical Inc

Current Assets 48m
Cash & Short-Term Investments 25.8m
Receivables 12m
Other Current Assets 10.1m
Non-Current Assets 21.6m
PP&E 13.3m
Intangibles 5.4m
Other Non-Current Assets 2.9m
Efficiency

Free Cash Flow Analysis
AVITA Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
AVITA Medical Inc

Revenue
71.7m USD
Cost of Revenue
-9.7m USD
Gross Profit
62m USD
Operating Expenses
-112.5m USD
Operating Income
-50.6m USD
Other Expenses
-6.5m USD
Net Income
-57m USD
Fundamental Scores

RCEL Profitability Score
Profitability Due Diligence

AVITA Medical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional 3-Years Revenue Growth
ROIC is Increasing
30/100
Profitability
Score

AVITA Medical Inc's profitability score is 30/100. The higher the profitability score, the more profitable the company is.

RCEL Solvency Score
Solvency Due Diligence

AVITA Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
38/100
Solvency
Score

AVITA Medical Inc's solvency score is 38/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

RCEL Price Targets Summary
AVITA Medical Inc

Wall Street analysts forecast RCEL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCEL is 17.85 USD with a low forecast of 14.14 USD and a high forecast of 23.1 USD.

Lowest
Price Target
14.14 USD
152% Upside
Average
Price Target
17.85 USD
218% Upside
Highest
Price Target
23.1 USD
311% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

AVITA Medical Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for RCEL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

RCEL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one RCEL stock?

The intrinsic value of one RCEL stock under the Base Case scenario is 32.05 USD.

Is RCEL stock undervalued or overvalued?

Compared to the current market price of 5.62 USD, AVITA Medical Inc is Undervalued by 82%.

Back to Top